Interferon β-1a in chronic inflammatory demyelinating polyneuropathy: Case report

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 3 B, 2004, Pages 892-894

  Villa, Andrés Maria ^a,b   Garcea, Orlando ^a   Di Egidio, Marianna ^a   Saizar, Roberto ^a   Sica, Roberto Eduardo Pedro ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL RAMOS MEJÍA   (Argentina)

Author keywords

CIDP; Interferon (IFN ); Peripheral neuropathy

Indexed keywords

BETA1A INTERFERON; HUMAN IMMUNOGLOBULIN; IMMUNOMODULATING AGENT;

ADULT; ARTICLE; ATAXIA; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; DISEASE COURSE; HUMAN; IMMUNE MEDIATED INJURY; IMMUNOMODULATION; MALE; NEUROPATHY; RELAPSE; SENSORY ATAXIC POLYNEUROPATHY;

EID: 5444239587     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2004000500031     Document Type: Article

References (11)

1. Vallat JM, Hahn AF, Leger JM, et al. Interferon beta-1a as an investigacional treatment for CIDP. Neurology 2003;60(Supp 3):S23-S28.
2. Villa AM, Molina H, Sanz OP, Sica REP. Chronic inflammatory demyelinating polyneuropathy. Findings in 30 patients. Medicina 1999;59:721-726.
3. AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.
4. Vallat JM, Tabaraud F, Magy L, et al. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle&Nerve 2003;27:478-485.
5. IFNB Múltiple Sclerosis Study Group. Inteferon beta 1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomised, double-blind, placebo-controlled trial. Neurology 1993;43:655-661.
6. Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta 1a for diseases progression in relapsing multiple sclerosis. Ann Neurol 1996;39:285-294.
7. The PRISMS (Prevention of Relapses and Disability by Interferon beta 1a Subcutaneously in Multiple Sclerosis) Study Group. Randomised double-blind placebo-controlled study of interferon beta 1a in relapsing-remitting multiple sclerosis. Lancet 1998;352:1498-1504.
8. Zang YCQ, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1(alpha) by interferon-(beta). J Neuroimmunol 2001;112:174-180.
9. Hadden RD, Sharrack B, Bensa S, Soudain SE, Huges RA. Randomized trial of interferon beta 1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 1999;53:57-61.
10. Kuntzer T, Radziwill AJ, Lettry-Trouillat R, et al. Interferon beta 1a in chronic inflammatory demyelinating polyneuropathy. Neurology 1999;53:1364-1365.
11. Van den Berg-Vos RM, Van den Berg RH, Fransen H, Van Doorn PA, Merkies IS, Wokke JH. Treatment of mulrifocal motor neuropathy with interferon beta 1a. Neurology 2000;54:1518-1521.